Anglo-Swedish pharmaceutical company AstraZeneca and India’s Ranbaxy have settled a legal dispute over the hugely profitable ulcer drug Nexium.
The agreement brings to an end a case that began in 2005 when AstraZeneca sued Ranbaxy in a federal court in New Jersey after Ranbaxy requested US Food and Drug Administration approval to sell its generic version of Nexium.
AstraZeneca alleged that Ranbaxy was violating patents on the drug, which is known generically as esomeprazole.
